Mark T. linthicum, MPP
peer-reviewed publications
Xie R.Z., E. dF. Malik, M. T. Linthicum, and J. L. Bright. Putting stakeholder engagement at the center of health economic modeling for health technology assessment in the United States. Pharmacoeconomics. 2021;39(6):631–638.
Jansen J. P., D. Incerti, and M. T. Linthicum. Developing open-source models for the US health system: Practical experiences and challenges to date with the Open-Source Value Project. Pharmacoeconomics. 2019;37(11):1313–1320.
Baumgardner J. R., A. Shahabi, M. T. Linthicum, C. Zacker, and D. N. Lakdawalla. Share of oncology versus nononcology spending in episodes defined by the Centers for Medicare & Medicaid Services Oncology Care Model. J Oncol Pract. 2018;14(11):e699–e710.
Baumgardner J. R., A. Shahabi, M. T. Linthicum, S. Vine, C. Zacker, and D. N. Lakdawalla. Greater spending associated with improved survival for some cancers in OCM-defined episodes. J Manag Care Spec Pharm. 2018;24(6):504–513.
Baumgardner J., A. Shahabi, M. T. Linthicum, S. Vine, C. Zacker, and D. N. Lakdawalla. Hematologic cancers more costly and have fewer savings options than solid tumors under the OCM. Blood. 2017;130(Supplement 1):4713.
Linthicum M. T., Y. S. Gonzalez, K. Mulligan, G. A. Moreno, D. Dreyfus, T. Juday, S. E. Marx, D. N. Lakdawalla, B. R. Edlin, and R. Brookmeyer. Value of expanding HCV screening and treatment policies in the United States. Am J Manag Care. 2016;22(6 Spec No.):Sp227–235.
Moreno G. A., K. Mulligan, C. Huber, M. T. Linthicum, D. Dreyfus, T. Juday, S. E. Marx, Y. S. Gonzalez, R. Brookmeyer, and D. N. Lakdawalla. Costs and spillover effects of private insurers’ coverage of hepatitis C treatment. Am J Manag Care. 2016;22(6 Spec No.):Sp236–244.
Linthicum M. T., J. Thornton Snider, R. Vaithianathan, Y. Wu, C. LaVallee, D. N. Lakdawalla, J. E. Benner, and T. J. Philipson. Economic burden of disease-associated malnutrition in China. Asia Pac J Public Health. 2015;27(4):407–417.
Lakdawalla D. N., J. W. Chou, M. T. Linthicum, J. P. MacEwan, J. Zhang, and D. P. Goldman. Evaluating expected costs and benefits of granting access to new treatments on the basis of progression-free survival in non-small-cell lung cancer. JAMA Oncol. 2015;1(2):196–202.
Snider J. T., A. B. Jena, M. T. Linthicum, R. A. Hegazi, J. S. Partridge, C. LaVallee, D. N. Lakdawalla, and P. E. Wischmeyer. Effect of hospital use of oral nutritional supplementation on length of stay, hospital cost, and 30-day readmissions among Medicare patients with COPD. Chest. 2015;147(6):1477–1484.
Stevens W., T. J. Philipson, Z. M. Khan, J. P. MacEwan, M. T. Linthicum, and D. P. Goldman. Cancer mortality reductions were greatest among countries where cancer care spending rose the most, 1995–2007. Health Aff (Millwood). 2015;34(4):562–570.
Eber M. R., D. P. Goldman, D. N. Lakdawalla, T. J. Philipson, D. Pritchard, M. Huesch, N. Summers, M. T. Linthicum, J. Sullivan, and R. W. Dubois. Clinical evidence inputs to comparative effectiveness research could impact the development of novel treatments. J Comp Eff Res. 2015:1–11.
Goldman D. P., T. Juday, D. Seekins, M. T. Linthicum, and J. A. Romley. Early HIV treatment in the United States prevented nearly 13,500 infections per year during 1996–2009. Health Aff (Millwood). 2014;33(3):362–369.
Gupta C., G. M. Chertow, M. T. Linthicum, K. Van Nuys, V. Belozeroff, D. Quarles, and D. N. Lakdawalla. Reforming Medicare’s dialysis payment policies: implications for patients with secondary hyperparathyroidism. Health Serv Res. 2014;49(6):1925–1943.
Lakdawalla D. N., J. T. Snider, D. J. Perlroth, C. LaVallee, M. T. Linthicum, T. J. Philipson, J. S. Partridge, and P. E. Wischmeyer. Can oral nutritional supplements improve Medicare patient outcomes in the hospital? Forum Health Econ Policy. 2014;17:131.
Lakdawalla D. N., M. Mascarenhas, A. B. Jena, J. Vanderpuye-Orgle, C. LaVallee, M. T. Linthicum, and J. T. Snider. Impact of oral nutrition supplements on hospital outcomes in pediatric patients. JPEN J Parenter Enteral Nutr. 2014;38(2 Suppl):42s–49s.
Philipson T., M. T. Linthicum, and J. T. Snider. Tutorial on health economics and outcomes research in nutrition. JPEN J Parenter Enteral Nutr. 2014;38(2 Suppl):5s–16s.
Ryan G. W., E. W. Bloom, D. J. Lowsky, M. T. Linthicum, T. Juday, L. Rosenblatt, S. Kulkarni, D. P. Goldman, and J. N. Sayles. Data-driven decision-making tools to improve public resource allocation for care and prevention of HIV/AIDS. Health Aff (Millwood). 2014;33(3):410–417.
Snider J. T., M. T. Linthicum, Y. Wu, C. LaVallee, D. N. Lakdawalla, R. Hegazi, and L. Matarese. Economic burden of community-based disease-associated malnutrition in the United States. JPEN J Parenter Enteral Nutr. 2014;38(2 Suppl):77s–85s.
Commentary & Op-Eds
Jansen J. P., M. T. Linthicum, and R. H. Chapman. Value assessment and decision making in the face of uncertainty. Health Affairs Forefront. 2022.
Linthicum M. T., J. F. Slejko, T. J. Mattingly, and J. L. Bright. The importance of collaboration in pursuit of patient-centered value assessment. The Patient – Patient-Centered Outcomes Research. 2021;14:381–384.
Lakdawalla D. N., M. T. Linthicum, and C. E. Phelps. How COVID can help us refocus on the how and why of value assessment. Health Affairs Forefront. 2021.
Bright J. L. and M. T. Linthicum. Value extends beyond the cost of drugs and health care. STAT News. March 14, 2019.
Linthicum M. T.. Why crowdsourcing for value in healthcare makes sense. AJMC.com. March 7, 2019.
Linthicum M. T.. To get our money’s worth in healthcare, we need to collaborate; test-drive this value-measurement tool. Modern Healthcare. 2018.
Bright J. and M. T. Linthicum. How a ‘waste-free formulary’ misses what’s most important to employers. Managed Care. 2018;27(9):30.
Linthicum M. T. Industry voices—it’s time to move to ‘value 2.0’ in healthcare. Fierce Healthcare. July 6, 2018.
Linthicum M. T., J. L. Bright, and J. Shafrin. Open-source tools for value assessment: a promising approach. Journal of Clinical Pathways. 2018;4(5):37–39.
Shafrin J. and M. T. Linthicum. Patient-centered formularies: steps in the right direction, but challenges remain. Health Affairs Blog. April 11, 2018.
Blumenthal D. M., S. Nussbaum, N. J. Weissman, and M. T. Linthicum. Using outcomes-based pricing for medical devices to improve cardiovascular disease treatment value. Health Affairs Blog. March 29, 2018.
Blumenthal D. M., M. T. Linthicum, and S. Kamal-Bahl. Strategies to address the challenges of outcomes-based pricing agreements for pharmaceuticals. Health Affairs Blog. April 3, 2017.
Jansen J. P., D. Incerti, and M. T. Linthicum. An open-source consensus-based approach to value assessment. Health Affairs Blog. December 15, 2017.
Linthicum M. T.. Why understanding value is central to true health care reform. Morning Consult. September 20, 2017.
Lakdawalla D. N., M. T. Linthicum, and J. Vanderpuye-Orgle. Does patient cost sharing for HCV drugs make sense? Am J Manag Care. 2016;22(6 Spec No.):Sp188–190.
Goldman D., D. Lakdawalla, J. Baumgardner, and M. T. Linthicum. Are biopharmaceutical budget caps good public policy? The Economists’ Voice. 2016;13(1):27–42.
Kamwi R. N., A. V. Holmes, M. M. Abaza, L. Husten, J. Bright, and M. T. Linthicum. Gene drive debate must include voices from Africa, elsewhere. STAT. 2016;15.
Shafrin J. and M. T. Linthicum. Advancing value in healthcare. Genetic Engineering and Biotechnology News. December 12, 2016.
Ward A. S., M. T. Linthicum, M. Drozd, A. R. Silverstein, and J. Vandigo. Regulatory, legal uncertainties are barriers to value-based agreements for drugs. Health Affairs Blog. November 4, 2016.
Goldman D. P., S. Nussbaum, and M. T. Linthicum. Rapid biomedical innovation calls for similar innovation in pricing and value measurement. Health Affairs Blog. September 15, 2016.
Goldman D. P., T. Juday, M. T. Linthicum, L. Rosenblatt, and D. Seekins. The prospect of a generation free of HIV may be within reach if the right policy decisions are made. Health Aff (Millwood). 2014;33(3):428–433.
Philipson T. J., M. T. Linthicum, and J. T. Snider. The global economic burden of malnutrition. Science. “Supplement, Addressing Malnutrition to Improve Global Health.”
Reports & white papers
Policy Symposium: Ensuring Equity in Implementation of IRA Drug Price Negotiations. Convening Proceedings Report. December 2023.
Linthicum M. T., M. Jalowsky, A. Valentine, R. Ahmed, J. Bright, and R. Chapman. Finding equity in value: racial and health equity implications of U.S. HTA processes. 2022.
conference presentations
Linthicum M. T., I. Zhang, and J. P. Jansen. PCN163 – Improvement of the Innovation & Value Initiative open-source cost-effectiveness model for non-small-cell lung cancer based on public feedback. ISPOR 2020. Value in Health. 2020;23:S51.
May S. G., C. Huber, A. R. Silverstein, et al. HSR19-099: Harnessing the voice of patients with genetic mutations in NSCLC treatment. J Natl Compr Canc Netw. 2019;17(3.5):HSR19-099.
May S. G., J. Shafrin, M. T. Linthicum, D. Incerti, J. P. Jansen, and J. Bright. PMS113 – Toward patient-centered value assessment: lessons from the IVI Open-Source Value Project. ISPOR 2018. Value in Health. 2018;21:S307.
Incerti D., J. Shafrin, D. N. Lakdawalla, L. Zhao, M. T. Linthicum, and J. P. Jansen. PCN167 – Improvement of an open-source cost-effectiveness model based on public feedback. ISPOR 2018. Value in Health. 2018;21:S42.
Linthicum M. T., T. Juday, G. Moreno, Y. S. Gonzalez, D. N. Lakdawalla, S. E. Marx, and B. R. Edlin. Awareness of hepatitis C status in HCV-infected US adults, 2003–2012. AASLD The Liver Meeting. November 2015.
Linthicum M. T., T. Juday, G. Moreno, Y. S. Gonzalez, D. N. Lakdawalla, S. E. Marx, and B. R. Edlin. Awareness of hepatitis C status in HCV-infected US adults, 2003–2012. AMCP Nexus. October 2015.
Jena A. B., M. T. Linthicum, R. Hegazi, J. Partridge, C. LaVallee, D. Lakdawalla, and P. Wischmeyer. The impact of oral nutritional supplementation in patients aged 65+ with COPD. 10th International Congress, European Union Geriatric Medicine Society (EUGMS). September 2014.
Jena A. B., M. T. Linthicum, R. Hegazi, J. Partridge, C. LaVallee, D. Lakdawalla, and P. Wischmeyer. The impact of oral nutritional supplementation in Medicare patients with COPD. European Society for Clinical Nutrition and Metabolism (ESPEN) Congress. September 2014.
Linthicum M. T., C. LaVallee, and D. Lakdawalla. The impact of oral nutritional supplementation in Medicare patients with COPD. ISPOR 19th Annual International Meeting. June 2014.
Lakdawalla D. N., J. Thornton, D. Perlroth, C. LaVallee, M. T. Linthicum, T. Philipson, J. Partridge, and P. Wischmeyer. Effect of oral nutritional supplements on hospital outcomes in patients aged 65+ with congestive heart failure. Value in Health. 2014;17(7):A503.
Lakdawalla D. N., D. J. Perlroth, C. LaVallee, M. T. Linthicum, and T. J. Philipson. Oral nutritional supplements’ impact on hospital outcomes in the context of the Affordable Care Act and new Medicare reimbursement policies. Society for Medical Decision Making Annual Meeting. October 2013.
Lakdawalla D. N., M. Mascarenhas, J. Vanderpuye-Orgle, C. LaVallee, and M. T. Linthicum. Use of oral nutrition supplements reduces length of stay and episode cost in hospitalized pediatric patients aged 2 to 8. North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Annual Meeting. October 2013.
Linthicum M. T.. Swept away: response to disaster in rural Honduras. Annual Meeting of the Society for Applied Anthropology. April 2005.